Showing 2551-2560 of 8640 results for "".
"Where to Start: Opening and Running a Private Practice" Drs. Jackson and Hooper
https://practicaldermatology.com/youngmd-connect/ymdc-workshops/where-to-start-opening-and-running-a-private-practice-drs-jackson-and-hooper/24544/Explore the essentials of starting and running a private practice in this unique webinar with Drs. Deirdre Hooper and Sarah Jackson. They cover practice setup, marketing, patient acquisition, and operational management, sharing invaluable insights for professional and financial success. To access moDermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-dermatologists-react-valisure-report-fda-approves-new-treatment-frown-lines/24157/In this episode of DermWireTV, dermatologists react to the recent Valisure report that found elevated levels of benzene when studied under laboratory conditions in certain acne products containing BPO; the FDA approves a new treatment option for glabellar lines; and the PA Perspectives series addresHow Air Pollution Affects the Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-air-pollution-affects-the-skin/20259/Mark Birch-Machin, PhD, a professor of molecular dermatology at New Castle University, talks about the effects that air pollution can have on skin. Dr. Birch-Machin also talks about a recent study his team published in FASEB BioAdvances looking at the effects of air pollution on human skin equivalenThe Latest in Hidradenitis Suppurativa (HS)
https://practicaldermatology.com/conferences/maui-derm-2024/the-latest-in-hidradenitis-suppurativa-hs/20251/Raj Chovatiya, MD, PhD, board-certified dermatologist and clinician investigator based in Chicago, discusses the incredible pipeline for Hidradenitis suppurativa (HS), as well as new and emerging treatment options.DermWireTV: ASDS Meeting Highlights; Daxxify Data; PA Week
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-asds-meeting-highlights-daxxify-data-pa-week/20147/ASDS speakers address aesthetic advancements, skin cancer, and DEI with Joel L. Cohen, MD, Sherrif Ibrahim, MD, and Jeanine Downie, MD. On the heels of FDA approval of Revance’s Daxxify, data published in the Aesthetic Surgery Journal demonstrate the efficacy of DaxibotulinumtoxinA for patients of dSocial media marketing trends for 2022 and beyond
https://practicaldermatology.com/topics/practice-management/social-media-marketing-trends-for-2022-and-beyond/20095/Social media is no longer the new frontier in digital marketing. It is a vital part of daily life for much of your audience. That means it is an indispensable part of a good marketing strategy for your dermatology practice. This short video from Ekwa Marketing (www.ekwa.com) covers the latest trendsScientifically Speaking: Managing Hair Loss Beyond PRP
https://practicaldermatology.com/series/scientifically-speaking/cientifically-speaking-managing-hair-loss-beyond-prp/20035/From documentary photographs to the potential for exosomes and the role of prescription therapies, many hot topics have emerged in the field of hair restoration. Glynis Ablon, MD and Jeffrey Rapaport, MD talk to host Joel L. Cohen, MD about clinical considerations beyond PRP.Liquid Rhinoplasty and Beyond: Injectable Pearls
https://practicaldermatology.com/series/scientifically-speaking/liquid-rhinoplasty-and-beyond-injectable-pearls/20008/From the best approach to safe and effective liquid nose corrections to tips for enhancing outcomes and streamline operations, Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share their best tips with host Joel L. Cohen, MD.Scientifically Speaking: New Directions in Acne Management, Part 2
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-2/19950/From the optimal, safe use of isotretinoin to the proper role for systemic antibiotics and beyond, there are multiple areas of systemic acne care that deserve attention. In the second of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD aAn Exciting Year in Dermatology
https://practicaldermatology.com/topics/psoriasis/an-exciting-year-in-dermatology/19929/From new topicals to novel systemic agents, several treatments may be coming to the market in the next two years, while existing therapies may see label expansions. Bruce Strober, MD, PhD offers a look at new MOAs and the evidence for their use.